Corona: What measures have Governments taken in the Life Sciences Sector?
Register now for ECA's GMP Newsletter
Governments have been implementing different emergency measures in the fight against the current pandemic. The Baker McKenzie Healthcare and Life Sciences Industry Group has now published an interesting overview of the different measures that various governments across the EMEA region (Europe, Middle East, Asia) have adopted in the area of healthcare and life sciences in response to the COVID-19 outbreak.
In this document, Baker McKenzie lawyers across EMEA share their high-level views on the following areas:
- Requisition powers
- Price and reimbursement
- Public procurement
- Legal deadlines
- Relaxation of regulatory rules
Related GMP News
17.09.2025When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
17.09.2025Dealing with Systems without Audit Trail Functionality
17.09.2025Why is RCA (Root Cause Analysis) so important?
10.09.2025The Use of Hoses in Pharmaceutical Production
10.09.2025Revision of EU-GMP Chapter 1 planned with Consultation Phase
10.09.2025Audit Trail Review by the QP / Dealing with a Lack of Justification